Jeffery Grein

Title: The Innovative Contributions of Jeffery Grein

Introduction

Jeffery Grein is a notable inventor based in Cupertino, CA (US). He has made significant contributions to the field of biotechnology, particularly in cancer therapies. With a total of 3 patents to his name, Grein's work has the potential to impact the medical community profoundly.

Latest Patents

Grein's latest patents include groundbreaking research on anti-cancer combination therapies. One of his notable inventions involves therapies comprising CTLA-4 and PD-1 blocking agents. This patent discloses combination therapies where the CTLA-4 blocking agent is an effector-silent anti-CTLA-4 antibody or fragment, paired with a PD-1 blocking agent, such as an anti-PD-1 or anti-PD-L1 antibody. Another significant patent involves nucleic acids encoding TNF-γ, which includes mammalian genes, purified proteins, and fragments. This invention also provides methods for using these compositions for diagnostic and therapeutic purposes.

Career Highlights

Throughout his career, Grein has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Schering Corporation, where he contributed to various innovative projects. His experience in these organizations has helped him refine his skills and expand his knowledge in the field.

Collaborations

Grein has collaborated with several professionals in his field, including Christi L Parham and Daniel M Gorman. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Jeffery Grein's innovative work in cancer therapies and biotechnology showcases his dedication to advancing medical science. His patents reflect a commitment to improving treatment options for patients, and his collaborations further enhance the impact of his contributions.